Pomdoctor Limited (POM)
NASDAQ: POM · Real-Time Price · USD
5.45
+0.71 (14.98%)
At close: Dec 5, 2025, 4:00 PM EST
5.95
+0.50 (9.17%)
After-hours: Dec 5, 2025, 7:57 PM EST
Pomdoctor Employees
Pomdoctor had 156 employees as of December 31, 2024. The number of employees decreased by 4 or -2.50% compared to the previous year.
Employees
156
Change
-4
Growth
-2.50%
Revenue / Employee
$328,274
Profits / Employee
-$133,239
Market Cap
645.51M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 156 | -4 | -2.50% |
| Dec 31, 2022 | 160 | -40 | -20.00% |
| Dec 31, 2020 | 200 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
POM News
- 2 days ago - POMDOCTOR LIMITED Announces First Half of Fiscal 2025 Unaudited Financial Results - PRNewsWire
- 7 weeks ago - Citi Appointed as Depositary Bank for POMDOCTOR LIMITED's ADR Program - Business Wire
- 2 months ago - U.S. IPO Weekly Recap: 6 IPOs Debut, Pipeline Grows, Despite Government Shutdown - Seeking Alpha
- 2 months ago - POMDOCTOR LIMITED Announces Full Exercise and Closing of Underwriter's Over-Allotment Option - PRNewsWire
- 2 months ago - PomDoctor Debuts On Nasdaq Ahead Of New Listing Rules - Benzinga
- 2 months ago - POMDOCTOR LIMITED Announces Closing of Initial Public Offering - PRNewsWire
- 2 months ago - POMDOCTOR LIMITED Announces Pricing of Initial Public Offering - PRNewsWire
- 4 months ago - PomDoctor Files For Nasdaq IPO That May Be Overvalued - Benzinga